Turkish Journal of Medical Sciences
Abstract
Background/aim: This study aimed to evaluate the frequency, timing, severity, and clinical predictors of systemic reactions in children receiving subcutaneous allergen-specific immunotherapy (SCIT) with house dust mite (HDM) and grass pollen extracts under real-world clinical conditions.
Materials and methods: This multicenter retrospective study included 623 children with moderate-to-severe allergic rhinitis, with or without asthma, who received SCIT between 2006 and 2023 at two tertiary pediatric allergy centers. Clinical characteristics, laboratory findings, immunotherapy protocols, and systemic reactions (SRs) were recorded and graded according to the updated 2024 World Allergy Organization (WAO) systemic reaction scale.
Results: SCIT was well tolerated. Systemic reactions occurred in 10.7%, corresponding to 0.27% per injection. Most SRs were mild-to-moderate (WAO grades 1–2), and approximately three-quarters occurred during the maintenance phase. A progressive decline in SR incidence was observed throughout the treatment period. In the pollen SCIT subgroup, asthma was the only independent predictor of SRs (OR, 2.35; 95% CI 1.13–4.88; p = 0.022). No life-threatening reactions or fatalities were observed.
Conclusion: Pediatric SCIT with pollen and HDM extracts demonstrated a favorable safety profile, with infrequent and predominantly nonsevere systemic reactions. The association between asthma and SRs in pollen SCIT highlights the importance of optimal asthma control throughout immunotherapy.
Author ORCID Identifier
FİGEN ÇELEBİ ÇELİK: 0000-0002-1100-4117
ALP KAZANCIOĞLU: 0000-0001-7185-8512
SONER GÜNDER: 0000-0002-0953-1380
MELİKE OCAK: 0000-0001-7841-4690
BERNA UZUNOĞLU: 0009-0008-5476-9743
CANAN KARKINER: 0000-0001-6662-8288
ÖZLEM SANCAKLI: 0000-0003-2489-4021
AYFER TUNCER: 0000-0001-7695-065X
ÖZGE UYSAL SOYER: 0000-0002-7444-251X
BÜLENT ŞEKEREL: 0000-0003-4232-3396
DEMET CAN: 0000-0002-1258-9348
ÜMİT ŞAHİNER: 0000-0003-0088-913X
DOI
10.55730/1300-0144.6347
Keywords
Asthma, pediatric, pollen, subcutaneous immunotherapy, systemic reactions
First Page
1031
Last Page
1039
Publisher
The Scientific and Technological Research Council of Türkiye (TÜBİTAK)
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
ÇELEBİ ÇELİK, F, KAZANCIOĞLU, A, GÜNDER, S, OCAK, M, UZUNOĞLU, B, KARKINER, C. Ş, SANCAKLI, Ö, TUNCER, A, UYSAL SOYER, Ö, ŞEKEREL, B. E, CAN, D, & ŞAHİNER, Ü. M (2026). Risk of systemic reactions during pediatric allergen-specific immunotherapy: clinical predictors and safety outcomes . Turkish Journal of Medical Sciences 56 (4): 1031-1039. https://doi.org/10.55730/1300-0144.6347